Open AccessCommentary: Induction Chemotherapy for Head and Neck Cancer: Hypothesis‐Based Rather Than Evidence‐Based Medicine
Author(s) -
Eisbruch Avraham
Publication year - 2007
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.12-8-975
Subject(s) - medicine , head and neck cancer , oncology , chemoradiotherapy , clinical trial , induction chemotherapy , chemotherapy , head and neck , cisplatin , radiation therapy , cancer , adjuvant chemotherapy , adjuvant , surgery , breast cancer
Learning Objectives After completing this course, the reader will be able to: Discuss the history of clinical trials using surgery, radiation, and chemotherapy in head and neck cancer. Explain the benefit of chemoradiotherapy in locally advanced head and neck cancer. Describe the role of adjuvant chemotherapy with cisplatin and 5‐FU followed by chemoradiation with or without taxanes. Evaluate the toxicity of adding taxanes and the need for further clinical trials adding taxanes.Access and take the CME test online and receive 1 AMA PRA Category 1 Credit ™ at CME.TheOncologist.com